Related Experiment Video
Updated: Mar 27, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Warfarin Management Pathway: A clear and safe algorithm, from admission to discharge
1NHS.
Implementing a warfarin management algorithm significantly reduced medication errors and clinician anxiety in a UK hospital. This quality improvement project demonstrates a safer approach to oral anticoagulant therapy, improving patient safety.
Area of Science:
- Pharmacology
- Patient Safety
- Health Services Research
Background:
- Warfarin is a common anticoagulant in the UK, frequently linked to medication errors and litigation.
- Life-threatening drug interactions and side effects necessitate improved prescribing and monitoring practices.
- The National Patient Safety Agency (NPSA) identified risks and advocated for safer anticoagulant therapy.
Purpose of the Study:
- To introduce and validate a management algorithm for oral anticoagulant therapy in hospital patients.
- To assess the impact of the algorithm on warfarin prescribing and management errors.
- To evaluate the effect of the algorithm on healthcare professionals' knowledge and anxiety levels.
Main Methods:
- A quality improvement project (QIP) was conducted at a district general hospital, involving all inpatient wards.
- Interviews with doctors and pharmacists assessed knowledge of warfarin management pathways.
- Hospital warfarin charts were audited before and after algorithm implementation to quantify errors.
Main Results:
- The implemented algorithm led to a marked decrease in medication errors on warfarin charts.
- Referrals for incomplete anticoagulation management were significantly reduced.
- Doctors reported a reduction in anxiety associated with prescribing warfarin.
Conclusions:
- A standardized warfarin management algorithm is an effective tool for improving patient safety in hospitals.
- The algorithm successfully reduced prescribing errors and enhanced clinician confidence.
- This quality improvement initiative offers a replicable model for safer anticoagulant therapy.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease IV: Nursing Management
Pulmonary Embolism III: Nursing Management

